• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Obagi Medical Products presents promising in vitro data for topical C serums

Article

Chicago - Obagi Medical Products announces in vitro data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, Skinceuticals, according to Marketwatch.com.

Chicago

- Obagi Medical Products announces

in vitro

data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, according to Marketwatch.com.

In addition, the Obagi Professional-C Serum had a five-fold greater absorption of vitamin C than the leading competitive product, and both Obagi products were proven to have a greater stability than the leading competitor.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.